Estrogen use has been associated with an increased risk for breast cancer and endometrial cancers in women (1-4). Various natural and synthetic estrogens also induce mammary, pituitary, cervical, uterine, and renal tumors in rodents (4-5). Diethylstilbestrol (DES), a synthetic estrogen, is well known to be carcinogenic to humans (6). The cellular and molecular mechanism(s) whereby estrogen-induced neoplastic events occur have not been fully elucidated, but there is strong evidence that estrogens are epigenetic carcinogens, acting via a promoting effect related to cellular proliferation, mediated through the estrogen receptor (7-15). However, it has been shown that estrogenic activity is not sufficient to explain the carcinogenic activity in vivo and in vitro under certain experimental conditions. Another mechanism, related to mutagenic changes, has been suggested in studies of estrogen-induced carcinogenesis (16) (17) (18) (19) (20) (21) (22) (23) (24) into the cellular and molecular mechanisms of carcinogenesis, which is difficult in whole-animal or human systems. We have used Syrian hamster embryo (SHE) fibroblast cell cultures as a model system to study the ability of estrogens to directly transform cells.
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Morphological and Neoplastic Transformation in Vitro by Estrogens and Estrogenlike Chemicals
Morphological and neoplastic transformation of SHE cells is induced by DES, 17,-estradiol (E2) and other estrogens. We observed that DES and E2 induce transformation of hamster cells that is indistinguishable from that induced by other chemical carcinogens such as benzo [a] pyrene (19, 25) . Sarcomas are also induced in Syrian hamsters in vivo following subcutaneous injection of DES (26) . SHE cells do not express measurable levels of estrogen receptor and estrogen treatment is not mitogenic to the cells (27) . Thus, estrogenic activity of the compounds can be excluded in this in vitro assay. The cells do, however, have the ability to metabolize estrogens (28, 29) , and the role of metabolic activation in the carcinogenesis activity of estrogens in this model is under investigation as discussed later.
The role of mutagenesis in the neoplastic transformation of SHE cells by estrogens has been studied extensively. We have demonstrated that treatment of SHE cells with DES or E2 induces cell transformation without measurable gene mutations, unscheduled DNA synthesis (UDS) or structural chromosome aberrations (19, 20, 23) . Under the same conditions, both estrogens induce a specific type of genetic change, i.e., aneuploidy. Chromosome losses and gains are induced (20, 23) , suggesting a nondisjunctional mechanism involved in the transforming activity. Structural analogues of DES have also been tested in this cell transformation system (25, 30 Rinehart et al. (35) showed that chronic exposure to DES of human endometrial stromal cells with a temperature-sensitive SV40 large T antigen induces a dose-dependent increase in the immortalization of cells, which is determined by the ability to grow at the restrictive temperature. Moreover, the increase in cell proliferation at the restrictive temperature is concurrent with alterations in p53 in the cells. As immortalization is an important step in the carcinogenesis process, and immortalization of human cells may be analogous to initiation of rodent cells, DES could act as an initiator in the carcinogenic process of human cells (35) .
We have studied the ability of estradiol (E2) and different metabolites of E2 to induce cell transformation. E2 metabolism is similar in rats and in humans. E2 is initially oxidized to estrone (E1), followed by hydroxylations at positions C-2 and 16ac that are mutually exclusive (5) . The principal products of 16a-hydroxylation are 16ax-hydroxyestrone (16ax-OH E1) and estriol (E3). 2-Hydroxylation yields the catechol estrogen 2-hydroxyestrone (2-OH E1) (36) . P450 multisubstrate monooxygenases catalyze the oxidative metabolism of estrogens, and estrogen 2-and 16a-hydroxylases play a major role in the metabolism of these estrogens (37) . E2 is also converted to catechol estrogen, postulated to arise from E2 via the 4-hydroxylation pathway, which is similar to the 2-hydroxylation pathway (38) . The catechol estrogens e.g., 2-OH E1, 2-hydroxyestradiol (2-OH E2), and 4-hydroxyestradiol (4-OH E2) seem to be further oxidized to quinones that covalently bind to DNA (39) .
We examined the transforming activity of these estrogens using the SHE cell assay system. Treatment of SHE cells with E1, E2, 16a-OH E1, 2-OH E1, or 2-OH E2 induces morphological transformation of cells in a dose-related manner. Exposure to E3 fails to elicit SHE cell transformation (unpublished data). Higher transforming activity is observed in cells treated with 166a-OH E1 or 2-OH E1, when compared to other estrogens. 16a-OH E1 could be capable of inducing UDS and anchorage-independent growth in mouse mammary epithelial cells (40) . Additionally, 16a-OH E1 binds covalently not only to nucleohistones in vitro (41) , but also to nudear regulatory proteins, specifically the estrogen receptor, in estrogen target cells (42) . This may disturb normal gene functions, possibly participating in the transformation process (41) . Elevated levels of 16x-hydroxylation are detected in breast tissue from women with breast cancer (43) and in mouse strains with a high incidence of mammary tumor formation (44 (20) . A nonrandom chromosome gain accompanies DESinduced immortalization and tumorigenic conversion of SHE cells (48) . These suggest that DES-induced aneuploidy is mechanistically involved in estrogen-induced cell transformation and possibly in carcinogenesis (7, 22) . E2 also induces a dose-dependent increase in the frequencies of aneuploid cells, corresponding to the inducibility of morphological transformation (23) .
E2 and DES bind and disrupt polymerization of microtubules in cultured mammalian cells (49) (50) (51) (52) (53) . DES inhibits in vitro assembly of microtubules purified from porcine brain (54) , and induces a decrease in the number of spindles and cytoplasmic microtubule fibers in SHE cells (49) and Chinese hamster V79 cells (50 (54) , but the quinone metabolites of both E2 and DES bind covalendy to the C-terminal regions of P-tubulin, which are important in regulation of microtubule assembly and disruption (55) . E2 exhibits microtubule-disrupting activity both in estrogen receptor-positive and receptor-negative human breast cancer cell lines (51) . The disrupting activity is demonstrated also in V79 cells (51, 52) , which have little capability of metabolizing xenobiotics (56) (63) (64) (65) (66) (67) . MN enclose acentric chromosome fragments or whole chromosomes that do not become incorporated into the main nuclei after cell division. MN are believed to arise from acentric chromosomal fragments or from chromosomes lagging at anaphase resulting from mitotic disturbance (68) . MN packing acentric chromosomal fragments appear to be induced by clastogens, while MN enclosing whole chromosomes are induced by agents that affect the mitotic apparatus. The majority of DES-induced and E2-induced MN contains whole chromosomes, which are demonstrated both with antikinetochore antibodies and with the centromerespecific DNA probe (67 (64) , which have both oxidative (28) and peroxidative activities (29) . Schnitzler et al. (67) have shown that the mechanism of DES-induced MN is different from that of E2-induced MN using SHE cells and ovine seminal cells. DES-induced MN can arise through chromosome nondisjunction due to spindle disruption, whereas E2 at the concentrations used in the MN assay exerts no detectable effect on the formation of the mitotic spindle, but causes chromosome dislocation, probably due to a functional loss of the mitotic apparatus.
Genotoxicity
Although DES is not genotoxic in many assays, in certain studies DES has been found to induce UDS (21, (70) (71) (72) , sister chromatid exchanges (73) (74) (75) , chromosome aberrations (76, 77) and gene mutations (33, 78) . The positive studies of DNA damage by DES use either cultured mammalian cells with exogenous metabolic activation or cells with possible endogenous activation capacity for DES. Therefore, we directly compared the cell transforming activity and genotoxicity of DES in the same cells with and without exogenous metabolic activation. When SHE cells are treated in the absence of a rat liver PMSmetabolic activation system, DES fails to induce DNA damage in SHE cells at doses that induce cell transformation (7, 19, 20, 21, 33) . However, treatment of SHE cells with DES in the presence of an exogenous metabolic activation system enhances the frequency of morphological transformation of the cells. Furthermore, this treatment elicits UDS and gene mutations in the cells at the Na+/K+-ATPase locus (33) . Thus, we have proposed two potential mechanisms for estrogen-induced cell transformation; in one the target of the estrogen is not DNA but rather microtubule disruption and the other is associated with DNA damage (33) . Both pathways may involve active genotoxic metabolites of DES. DNAAdduct Formation Cellular DNA damage induced by chemicals can be examined by detection of DNA adduct formation through a covalent modification of DNA. Liehr et al. (79) demonstrated the presence of covalent DNA adducts in premalignant kidneys of Syrian hamsters treated chronically with DES using a sensitive 32P-postlabeling assay.
Because structurally diverse estrogens induced identical DNA adducts, they concluded that estrogens induce binding of the same unknown endogenous compounds to target tissue DNA. They also reported that a distinct pattern of DNA adducts was detected in the liver, kidney, uterus, and testes of Syrian hamsters following treatment with DES (80), and the major adducts found were similar to those produced by reaction of diethylstilbestrol-4',4"-quinone with DNA (39) . This suggests that DES acts as a genotoxic carcinogen via its metabolic activation to the electrophilic 4',4"-quinone (39) . There is another possible mechanism by which DES may cause DNA damage. Microsomemediated redox cycling between DES or its catechol and the corresponding quinones generates superoxide radicals (02--) and hydroxyl radicals (OH) (81) (82) (83) (84) . Free radicals generated by the redox cycling of DES also oxidize 2'-deoxyguanosine to 8-hydroxy-2'-deoxyguanosine in vitro (85) as well as in vivo (86) . Small DNA adducts such as 8-OH-dG could be a causal basis for DES-induced DNA damage, which is detected as gene mutations and UDS in cultured SHE cells (21, 33) .
Chronic exposure of Syrian hamsters to E2 for 6 months induces renal tumors (6) , and the treatment causes covalent DNA alterations (adduct formation) in the kidney (82 (55, 88, 89) and generation of reactive oxygen species (39, 81, 83, 84, 86) could participate into inducing transformed cells. Furthermore, we cannot rule out the possibility that multiple effects of estrogens act together to cause genetic alterations leading to cell transformation. Our studies do, however, suggest that estrogens have the ability to directly transform cells by multiple mutagenic mechanisms unrelated to estrogenicity. These estrogen-induced changes, in conjunction with epigenetic changes mediated through the estrogen receptor, may contribute to hormonal carcinogenesis.
